Cardiovascular Diseases

Subclinical Coronary Atherosclerosis Linked to Higher MI Risk

A prospective Danish cohort study revealed that subclinical obstructive coronary atherosclerosis is associated with a more than 8-fold elevated risk for myocardial infarction (MI). The study included 9533 asymptomatic persons aged 40 years or older without known ischemic heart disease. Coronary atherosclerosis was assessed with coronary computed tomography angiography and characterized according to luminal obstruction (≥50% luminal stenosis or not) and extent (≥1/3 of the coronary tree or not). A total of 54% had no subclinical coronary atherosclerosis, 36% had nonobstructive disease, and 10% had obstructive disease. In a median follow-up of 3.5 years (range, 0.1 to 8.9 years), 193 patients died and 71 had MI. The MI risk was increased in patients with obstructive (adjusted relative risk, 9.19) and extensive (7.65) disease. The highest MI risk was noted in patients with obstructive-extensive subclinical coronary atherosclerosis (adjusted relative risk, 12.48) or obstructive-nonextensive (adjusted relative risk, 8.28). This contrasts with symptomatic populations where nonobstructive disease accounts for most future MI, presumably from plaque rupture. The risk for the composite of death or MI was increased in patients with extensive coronary atherosclerosis, regardless of degree of obstruction. The study provides a benchmark about event rates and prevalence of asymptomatic coronary artery disease and indicates that screening for patients with obstructive and/or extensive subclinical coronary atherosclerosis could benefit from primary prevention intervention. Source: https://www.acpjournals.org/

hyangiu

Recent Posts

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

1 day ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 days ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 week ago

Hyperlipidemias and Inflammation Independently and Synergistically Raise CVD Risk

A UK longitudinal associations study revealed that hyperlipidemias and inflammation independently and together raise the…

2 weeks ago

Ultraprocessed Food Consumption and Early Death

A study shows that eating a lot of highly processed foods is likely causing a…

3 weeks ago

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

3 weeks ago

This website uses cookies.